The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
The emerging problem of linezolid-resistant Staphylococcus
Open accessAbstract
The oxazolidinone antibiotic linezolid has demonstrated potent antimicrobial activity against Gram-positive bacterial pathogens, including methicillin-resistant staphylococci. This article systematically reviews the published literature for reports of linezolid-resistant Staphylococcus (LRS) infections to identify epidemiological, microbiological and clinical features for these infections. Linezolid remains active against >98% of Staphylococcus, with resistance identified in 0.05% of Staphylococcus aureus and 1.4% of coagulase-negative Staphylococcus (CoNS). In all reported cases, patients were treated with linezolid prior to isolation of LRS, with mean times of 20.0 ± 47.0 months for S. aureus and 11.0 ± 8.0 days for CoNS. The most common mechanisms for linezolid resistance were mutation (G2576T) to the 23S rRNA (63.5% of LRSA and 60.2% of LRCoNS) or the presence of a transmissible cfr ribosomal methyltransferase (54.5% of LRSA and 15.9% of LRCoNS). The emergence of linezolid resistance in Staphylococcus poses significant challenges to the clinical treatment of infections caused by these organisms, and in particular CoNS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,033
Self-citationDiekema, D. J., & Jones, R. N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06964-1 · Cited by 378
Resistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome
Long, K. S., & Vester, B. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05702-11 · Cited by 375
Toh, S., Xiong, L., Arias, C. A., Villegas, M. V., Lolans, K., Quinn, J., & Mankin, A. S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05744.x · Cited by 338
Morales, G., Picazo, J. J., Baos, E., Candel, F. J., Arribi, A., Peláez, B., Andrade, R., de la Torre, M., Fereres, J., & Sánchez‐García, M. (2010) · Clinical Infectious Diseases · doi:10.1086/650574 · Cited by 292
Linezolid resistance in clinical isolates of Staphylococcus aureus
Wilson, P. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg104 · Cited by 289
Sánchez García, M. (2010) · JAMA · doi:10.1001/jama.2010.757 · Cited by 270
Meka, V. G., Pillai, S. K., Sakoulas, G., Wennersten, C., Venkataraman, L., DeGirolami, P. C., Eliopoulos, G. M., Moellering, Jr., & Gold, H. S. (2004) · The Journal of Infectious Diseases · doi:10.1086/421471 · Cited by 247
Widerström, M., Wiström, J., Sjöstedt, A., & Monsen, T. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1270-6 · Cited by 169
Chua, K., Laurent, F., Coombs, G., Grayson, M. L., & Howden, B. P. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq067 · Cited by 159
Mendes, R. E., Deshpande, L. M., Farrell, D. J., Spanu, T., Fadda, G., & Jones, R. N. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq331 · Cited by 155
Daptomycin Nonsusceptible Enterococci: An Emerging Challenge for Clinicians
Kelesidis, T., Humphries, R. M., Uslan, D. Z., & Pegues, D. A. (2010) · Clinical Infectious Diseases · doi:10.1093/cid/ciq113 · Cited by 145
Self-citationJones, R. N., Fritsche, T. R., Sader, H. S., & Ross, J. E. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.06.004 · Cited by 129
Gales, A. C., Sader, H. S., ANDRADE, S., Lutz, L., MACHADO, A., & Barth, A. L. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.11.008 · Cited by 124
Endimiani, A., Blackford, M. G., Dasenbrook, E. C., Reed, M. D., Bajaksouszian, S., Hujer, A. M., Rudin, S. D., Hujer, K. M., Perreten, V., Rice, L. B., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01308-10 · Cited by 122
Bonilla, H. F., Huband, M. D., Seidel, J., Schmidt, H., Lescoe, M., McCurdy, S. P., Lemmon, M. M., BRENNAN, L., Tait-Kamradt, A. G., Puzniak, L., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/656281 · Cited by 108
United States resistance surveillance results for linezolid (LEADER Program for 2007)
Jones, R. N., Ross, J. E., Castanheira, M., & Mendes, R. E. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.10.010 · Cited by 101
Sader, H. S., & Jones, R. N. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.06.016 · Cited by 100
Linezolid surveillance program results for 2008 (LEADER Program for 2008)
Farrell, D. J., Mendes, R. E., Ross, J. E., & Jones, R. N. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.10.011 · Cited by 95
Farrell, D. J., Mendes, R. E., Ross, J. E., Sader, H. S., & Jones, R. N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01729-10 · Cited by 93
Draghi, D. C., Sheehan, D. J., Hogan, P. A., & Sahm, D. F. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.5024-5032.2005 · Cited by 92
Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus
Meka, V. G., Gold, H. S., Cooke, A., Venkataraman, L., Eliopoulos, G. M., Moellering, R. C., & Jenkins, S. G. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh423 · Cited by 89
Mendes, R. E., Deshpande, L. M., Rodríguez-Noriega, E., Ross, J. E., Jones, R. N., & Morfín‐Otero, R. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00880-10 · Cited by 78
Jones, R. N., Kohno, S., Ono, Y., Ross, J. E., & Yanagihara, K. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.03.001 · Cited by 77
Jones, R. N., Ross, J. E., Fritsche, T. R., & Sader, H. S. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki437 · Cited by 74
Clinical Characteristics of Linezolid-Resistant Staphylococcus aureus Infections
Peeters, M. J., & Sarria, J. C. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200508000-00007 · Cited by 67
Tenover, F. C., Williams, P. P., Stocker, S. A., Thompson, A. D., Clark, L. A., Limbago, B. M., Carey, R. B., Poppe, S. M., Shinabarger, D. L., & McGowan, J. E. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00913-07 · Cited by 65
Pillar, C. M., Draghi, D. C., Sheehan, D. J., & Sahm, D. F. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.08.007 · Cited by 63
Hill, R. L. R., Kearns, A. M., Nash, J., North, S. E., Pike, R., Newson, T., Woodford, N., Calver, R., & Livermore, D. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp494 · Cited by 57
Bongiorno, D., Campanile, F., Mongelli, G., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq344 · Cited by 54
Ross, J. E., Farrell, D. J., Mendes, R. E., Sader, H. S., & Jones, R. N. (2011) · Journal of Chemotherapy · doi:10.1179/joc.2011.23.2.71 · Cited by 53
Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan
Ikeda-Dantsuji, Y., Hanaki, H., Sakai, F., et al. (2010) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0085-1 · Cited by 49
Sequential Linezolid-Resistant Staphylococcus epidermidis Isolates with G2576T Mutation
Hong, T., Li, X., Wang, J., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02048-06 · Cited by 33
Zhu, W., Tenover, F. C., Limor, J. R., Lonsway, D. R., Prince, D., Dunne, W. M., & Patel, J. B. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0261-0 · Cited by 30
Ball, A. T., Xu, Y., Sanchez, R. J., Shelbaya, A., Deminski, M. C., & Nau, D. P. (2010) · Clinical Therapeutics · doi:10.1016/s0149-2918(10)80027-x · Cited by 14
Cited by
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
Coagulase-Negative Staphylococci
Becker, K., Heilmann, C., & Peters, G. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00109-13 · Cited by 1,628
Nanotechnology as a therapeutic tool to combat microbial resistance
Pelgrift, R. Y., & Friedman, A. J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.011 · Cited by 1,432
What is a resistance gene? Ranking risk in resistomes
Martínez, J. L., Coque, T. M., & Baquero, F. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3399 · Cited by 1,001
Metadata
- Authors
- Gu, B., Kelesidis, T., Tsiodras, S., Hindler, J., & Humphries, R. M.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-09-04
- Volume
- 68
- Issue
- 1
- Pages
- 4-11
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2104273970
- Cited by
- 332
- References
- 35
- FWCI
- 17.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.